Two people in this thread mean different things by gallbladder disease risk and are disagreeing about the definition while believing they are disagreeing about the facts. Worth pausing to define it.
Gallbladder disease risk with rapid weight loss
Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without diabetes; SUSTAIN 6 was in high-risk diabetes. Absolute benefit is largest in high-risk people.
It cost nothing to check and would have cost something not to.
Where the gallbladder disease risk discussion usually stalls is that nobody wants to say "I do not know" and everyone is willing to say "it varies". Those are the same sentence with different clothes on.
The bit of gallbladder disease risk that nobody enjoys is that the answer changes depending on what you are trying to decide with it. Say what the decision is and the thread will converge.
Narrowing post #26, because the general version has more than one answer.
Gallbladder disease risk came up in a thread eighteen months ago and was answered well. I cannot find it, which is itself the problem, so here is the reconstruction.
Cardiovascular disease: several compounds have cardiovascular outcome trials. SELECT was in people without diabetes; SUSTAIN 6 was in high-risk diabetes. Absolute benefit is largest in high-risk people.
The claim is narrower than it sounds, and deliberately so.
Interactions between comorbidities: diabetes and kidney disease together change the risk calculation for hypoglycemia and for medication clearance. They are not independent variables.
I have separated what I observed from what I concluded, which does not always happen.
Read the full topic (64 posts)
This topic was referenced in
- Cardiovascular risk: reading the outcome trials as a setClinical › Comorbidities · 4 replies
- Heart failure with preserved ejection fraction: symptom endpointsClinical › Comorbidities · 23 replies
Suggested topics
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Gastro-oesophageal reflux: improving or worsening?
The question in the title: Gastro-oesophageal reflux: improving or worsening? I will give what I have already checked below so nobody repeats it. Collecting what is known about gastro-oesophageal reflux in…
|
+54 | 58 | 8.2k | 1mo |
|
Obstructive sleep apnoea and a hard endpoint in this class
On the subject in the title: Obstructive sleep apnoea and a hard endpoint in this class Working notes rather than a conclusion. I was wrong about obstructive sleep apnoea in a thread last spring and I would…
|
+120 | 129 | 1.8k | 13mo |
|
About the Comorbidities category
Type 2 diabetes, hepatic steatosis, sleep apnoea, cardiovascular and renal disease. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author…
|
4 | 16k | 12h | |
|
Osteoarthritis and mechanical versus metabolic improvement
Osteoarthritis and mechanical versus metabolic improvement Writing it up because I had to work it out twice and would rather nobody else did. Asking about osteoarthritis and mechanical versus metabolic…
|
+2 | 6 | 30k | 12h |
|
Heart failure with preserved ejection fraction: symptom endpoints
Heart failure with preserved ejection fraction: symptom endpoints — setting out what I have, and where I think it stops being reliable. Heart failure with preserved ejection keeps being re-asked here and I…
|
+19 | 23 | 311 | 12d |
Related topics — sharing the tags obstructive sleep apnoea, type 2 diabetes, chronic kidney disease
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Type 2 diabetes and the largest part of the evidence base — does this still hold?
Type 2 diabetes and the largest part of the evidence base — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Trying to work out what would count…
|
+17 | 22 | 4.5k | 1d |
|
Obstructive sleep apnoea and a hard endpoint in this class
On the subject in the title: Obstructive sleep apnoea and a hard endpoint in this class Working notes rather than a conclusion. I was wrong about obstructive sleep apnoea in a thread last spring and I would…
|
+120 | 129 | 1.8k | 13mo |
|
Coming back to: Semaglutide half-life: where the 165 to 184 hour figure comes from
Semaglutide half-life: where the 165 to 184 hour figure comes from Writing it up because I had to work it out twice and would rather nobody else did. Putting the numbers in the first post, because a question…
|
+112 | 119 | 3.3k | 11mo |
|
Revisiting: Heart failure with preserved ejection fraction: symptom endpoints
On the subject in the title: Revisiting: Heart failure with preserved ejection fraction: symptom endpoints Working notes rather than a conclusion. Working notes on Heart failure with preserved ejection rather…
|
+4 | 8 | 43k | 17mo |
|
About the Sleep category
Sleep quality, apnoea, and the bidirectional relationship with metabolic health. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its author and…
|
+1 | 5 | 92 | 4mo |